Normal tissue protection in cancer therapy - Progress and prospects

Pathirissery Uma Devi

Research output: Contribution to journalReview articlepeer-review

46 Citations (Scopus)


Normal tissue tolerance is a major dose-limiting factor in radiotherapy and chemotherapy of cancer. During the past few decades several investigations have been directed toward increasing normal tissue tolerance by using chemical protectors against radiation and drug toxicity. WR-2721, the phosphorylated aminothiol, synthesized in the 1960s, has been hailed as the best chemical protector discovered so far. But its systemic toxicity after repeated administration in cancer patients during clinical trials has been a deterrent against its acceptance in routine radiotherapy, though more encouraging results have been reported with chemotherapy. The 1980s found a surge of activity in the field of chemical protection research, which has resulted in the discovery of many non-thiol protectors, particularly the biological response modifiers and antioxidants. It has also been found that protection by WR-2721 can be improved and its toxicity reduced by combination with some low potent protective chemicals. This review analyzes the major reports on chemical protectors published during the past ten years.

Original languageEnglish
Pages (from-to)247-252
Number of pages6
JournalActa Oncologica
Issue number3
Publication statusPublished - 15-07-1998
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology


Dive into the research topics of 'Normal tissue protection in cancer therapy - Progress and prospects'. Together they form a unique fingerprint.

Cite this